Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
BBB Foods | TBBB | 3. fév 2025 | 31.23 | +0.68 |
BCB Bank | BCBP | 3. fév 2025 | 10.66 | -1.57 |
BCE | BCE | 3. fév 2025 | 24.03 | +1.01 |
Beachbody A | BODI | 3. fév 2025 | 7.69 | +3.78 |
Beacon Roofing Supply | BECN | 3. fév 2025 | 117.50 | -0.71 |
Beam Global | BEEM | 3. fév 2025 | 2.59 | -3.00 |
Beam Therapeutics | BEAM | 3. fév 2025 | 25.59 | -1.27 |
Beamr Imaging | BMR | 3. fév 2025 | 3.55 | -0.84 |
Beasley Broadcast A | BBGI | 3. fév 2025 | 8.12 | +0.87 |
Beazer Homes USA | BZH | 3. fév 2025 | 21.33 | -3.75 |
Becton, Dickinson And Co | BDX | 3. fév 2025 | 247.61 | +0.00 |
BeiGene ADR | ONC | 3. fév 2025 | 223.37 | -0.72 |
Bel Fuse A | BELFA | 3. fév 2025 | 81.27 | -1.62 |
Bel Fuse B | BELFB | 3. fév 2025 | 78.18 | -3.60 |
Belden | BDC | 3. fév 2025 | 113.44 | -2.60 |
Belgium Investable Mkt Idx MSCI Ishares | EWK | 3. fév 2025 | 18.28 | -1.67 |
Belite Bio ADR | BLTE | 3. fév 2025 | 57.72 | -0.55 |
Bellevue Life Sciences Acquisition | BLAC | 3. fév 2025 | 11.30 | -0.44 |
Bellevue Life Sciences Acquisition Unit | BLACU | 3. fév 2025 | 11.31 | 0.00 |
BellRing Brands | BRBR | 3. fév 2025 | 78.25 | +1.16 |
Belpointe Prep A | OZ | 3. fév 2025 | 61.89 | +0.64 |
Benchmark Electronics | BHE | 3. fév 2025 | 41.14 | -3.56 |
Beneficient A | BENF | 3. fév 2025 | 0.61 | -0.99 |
Benitec Biopharma | BNTC | 3. fév 2025 | 11.80 | +2.70 |
Benson Hill | BHIL | 3. fév 2025 | 2.18 | -16.48 |
Bentley Systems B | BSY | 3. fév 2025 | 45.86 | -1.48 |
Berkshire Hathaway A | BRK-A | 3. fév 2025 | 696 552.00 | -0.86 |
Berkshire Hathaway B | BRK-B | 3. fév 2025 | 464.61 | -0.87 |
Berkshire Hills Bancorp | BHLB | 3. fév 2025 | 28.94 | -1.60 |
Berry | BRY | 3. fév 2025 | 4.25 | -2.52 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.